Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV

Affiliations

• ¹ Division of Infectious Diseases, the University of North Carolina at Chapel Hill, Chapel Hill, NC.
• ² Department of Biostatistics, Center for Biostatistics and AIDS Research,Harvard T. H. Chan School of Public Health, Boston, MA.
• ³ Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD.
• ⁴ Department of Clinical Research, Social and Scientific Systems, Inc, a DLH Company, Silver Spring, MD.
• ⁵ Division of Infectious Diseases, University of California, San Diego, CA.
• ⁶ Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL.
• ⁷ Semel Institute for Neuroscience and Human Behavior, Center for AIDS Research and Education (CARE), University of California, Los Angeles, CA.
• ⁸ Division of Infectious Diseases, Northwestern University, Chicago, IL.
• ⁹ Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA.
• ¹⁰ Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
• ¹¹ Clinical Sciences, Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, NY.
• ¹² HIV Research Branch, Division of AIDS, National Institute of AIDS, National Institutes of Health, Rockville, MD.
• ¹³ Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.